Comparison of QuantiFERON TB-G-test to TST for detecting latent tuberculosis infection in a high-incidence area containing BCG-vaccinated population.

OBJECTIVE Until recently, the only tool for detection of latent tuberculosis infection (LTBI) was the tuberculin skin test (TST). QuantiFERON-TB Gold In-Tube test (QFT) is a promising in vitro diagnostic test for LTBI that has potential advantages over the TST. In this study we aimed to compare QFT with TST for diagnosis of LTBI. PATIENTS AND METHODS A total of 186 BCG-vaccinated subjects enrolled in study. They underwent TST and QFT assay. They divided in two groups. Group 1 includes individuals who were at low risk for exposure to M. tuberculosis (LRG) and Group 2 includes individuals who were likely to have been exposed to M. tuberculosis infections (HRG). RESULTS Overall agreement between QFT and TST was 89.3% (kappa = 0.052). In LRG, agreement between the two tests was 52.6% (95% confidence interval, 44-60%) with kappa-values of 0.019. In HRG agreement between the two tests was 63.2% (95% confidence interval, 42-84%) with kappa-values of 0.28. CONCLUSION In conclusion, the QFT assay showed acceptable results for determining latent M. tuberculosis infection in vaccinated population. The decision to select QFT over TST will depend on the population, purpose of testing and resource availability.

[1]  M. Pai,et al.  Comparison of a whole blood interferon-gamma assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India. , 2007, The Journal of infection.

[2]  S. Niemann,et al.  Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test , 2006, European Respiratory Journal.

[3]  R. Joshi,et al.  Persistently elevated T cell interferon-γ responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report , 2006, Journal of occupational medicine and toxicology.

[4]  S. Kalantri,et al.  New tools and emerging technologies for the diagnosis of tuberculosis: Part I. Latent tuberculosis , 2006, Expert review of molecular diagnostics.

[5]  J. Musser,et al.  Comparison of a New ESAT-6/CFP-10 Peptide-Based Gamma Interferon Assay and a Tuberculin Skin Test for Tuberculosis Screening in a Moderate-Risk Population , 2006, Clinical and Vaccine Immunology.

[6]  B. Metchock,et al.  Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. , 2005, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[7]  P. Barnes,et al.  Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection. , 2005, American journal of respiratory and critical care medicine.

[8]  L. Fabbri,et al.  Routine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. , 2005, American journal of respiratory and critical care medicine.

[9]  R. Joshi,et al.  Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. , 2005, JAMA.

[10]  J. Yim,et al.  Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. , 2005, JAMA.

[11]  K. Dheda,et al.  Utility of the antigen-specific interferon-γ assay for the management of tuberculosis , 2005, Current opinion in pulmonary medicine.

[12]  C. Litwin,et al.  Evaluation of an In Vitro Assay for Gamma Interferon Production in Response to Mycobacterium tuberculosis Infections , 2004, Clinical Diagnostic Laboratory Immunology.

[13]  P. Andersen,et al.  Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. , 2004, American journal of respiratory and critical care medicine.

[14]  Y. Sasaki,et al.  Specific Detection of Tuberculosis Infection: An Interferon-γ–based Assay Using New Antigens , 2004 .

[15]  R. Adegbola,et al.  Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  Christopher Dye,et al.  The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. , 2003, Archives of internal medicine.

[17]  P. Fine,et al.  Kinetics of delayed-type hypersensitivity to tuberculin induced by bacille Calmette-Guérin vaccination in northern Malawi. , 2002, The Journal of infectious diseases.

[18]  T. Ottenhoff,et al.  Tuberculin Skin Testing Compared with T-Cell Responses to Mycobacterium tuberculosis-Specific and Nonspecific Antigens for Detection of Latent Infection in Persons with Recent Tuberculosis Contact , 2001, Clinical Diagnostic Laboratory Immunology.

[19]  W. Bishai,et al.  Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. , 2001, JAMA.

[20]  J. Deeks,et al.  Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells , 2001, The Lancet.

[21]  P. Andersen,et al.  Specific immune-based diagnosis of tuberculosis , 2000, The Lancet.

[22]  D. Menzies,et al.  What does tuberculin reactivity after bacille Calmette-Guérin vaccination tell us? , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  P. Andersen,et al.  Diagnosis of Tuberculosis Based on the Two Specific Antigens ESAT-6 and CFP10 , 2000, Clinical Diagnostic Laboratory Immunology.

[24]  C. Dye,et al.  Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. , 1999, JAMA.

[25]  N. Desem,et al.  Development of a Human Gamma Interferon Enzyme Immunoassay and Comparison with Tuberculin Skin Testing for Detection ofMycobacterium tuberculosis Infection , 1998, Clinical Diagnostic Laboratory Immunology.

[26]  R. Huebner,et al.  The tuberculin skin test. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.